An overview of some potential immunotherapeutic options against COVID-19

M Bayat, Y Asemani, MR Mohammadi, M Sanaei… - International …, 2021 - Elsevier
… key immunotherapeutic approaches to deal with COVID-19, which is discussed in this review…
Also, details of leading COVID-19 vaccine candidates as the most potent immunotherapy

The possible of immunotherapy for COVID-19: A systematic review

A AminJafari, S Ghasemi - International immunopharmacology, 2020 - Elsevier
… review, immunotherapy is an efficient therapeutic option intervention against COVID-19 and
the … and plasma therapy have improved clinical outcomes in COVID-19 infected patients. …

Immunotherapeutic approaches to curtail COVID-19

H Owji, M Negahdaripour, N Hajighahramani - International …, 2020 - Elsevier
… administration, passive immunotherapy by convalescent … immunotherapeutic approaches
that will be mentioned in this review. The focus would be on passive immunotherapeutic

[HTML][HTML] A guide to immunotherapy for COVID-19

FL van de Veerdonk, E Giamarellos-Bourboulis… - Nature medicine, 2022 - nature.com
… strategies that are supported in expert guidelines, such as anti-IL-6R blockade and
corticosteroids; however, we will augment this guidance with possible treatment options for when …

[HTML][HTML] Potential therapeutic options for COVID-19: current status, challenges, and future perspectives

C Sarkar, M Mondal, M Torequl Islam… - Frontiers in …, 2020 - frontiersin.org
… Passive immunotherapy has been used as a reliable treatment option for many infectious …
, and immunogenicity of passive immunotherapy for the treatment of COVID-19. As of now on 9 …

Immunobiology and immunotherapy of COVID19: A clinically updated overview

A Esmaeilzadeh, R Elahi - Journal of cellular physiology, 2021 - Wiley Online Library
… clinical data on the immunopathogenesis of the COVID19 and review the innate and adaptive
immunotherapies as well as reviewing recruiting/completed clinical trials of COVID19. …

COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics

K Dhama, K Sharun, R Tiwari, M Dadar… - … immunotherapeutics, 2020 - Taylor & Francis
… Most of the therapeutic options that are available for managing COVID-19 are based …
COVID-19. Citation16 The major therapeutic drugs that might be effective in managing COVID-19

[HTML][HTML] Potential therapeutic options for COVID-19: an update on current evidence

Z Niknam, A Jafari, A Golchin, F Danesh Pouya… - European journal of …, 2022 - Springer
… treatments as a kind of passive immunotherapy may be appropriate to achieve COVID-19
treatment [66]. In this section, immunotherapy based on the antibody include neutralizing …

[HTML][HTML] Neurological immunotherapy in the era of COVID-19—looking for consensus in the literature

C Korsukewitz, SW Reddel, A Bar-Or… - Nature reviews …, 2020 - nature.com
option) during the COVID-19 pandemic, and the first reports of SARS-CoV-2 infection in
patients receiving natalizumab therapy have suggested no increase in risk 67,68 . Furthermore, …

[HTML][HTML] Adjunct immunotherapies for the management of severely ill COVID-19 patients

SR Bonam, SV Kaveri, A Sakuntabhai, L Gilardin… - Cell Reports …, 2020 - cell.com
… characterize the early immune response to COVID-19 that causes severe lung damage and
immunotherapies as an adjunct therapy in severe COVID-19 cases. Such immunotherapies